From the bulletin: Compounded drugs containing BPC-157 may pose risk for immunogenicity for certain routes of administration and may have complexities with regard to peptide-related impurities and active pharmaceutical ingredient (API) characterization
For individuals using injections for general health and wellness, monthly injections may be sufficient
Oral or troche dose: Determined at APRN intake based on your GI indication and treatment goal Troche format: Held sublingually for 60 to 90 seconds before swallowing for improved absorption Best use case: GI inflammation, IBS, gut lining repair, Crohns management, systemic anti-inflammatory support Not optimal for: Localized tendon, joint, or muscle injury where injection near the site is more targeted Injury vs Gut Protocol: See What Dosing Looks Like for Your Use Case BPC-157 dosage differs by indication
Administration Methods BPC-157 is commonly administered via subcutaneous injection
Thank you to the teams, investigators and, most importantly, the patients whose partnership makes this work possible
In this condition, red blood cells are larger and fewer in number, which can result in reduced oxygen-carrying capacity and lead to fatigue, pale skin, and shortness of breath
